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Introduction
Scramblases are a family of four proteins in humans and mice. 
They are conserved across species, and at least one member of 
this family is encoded in organisms ranging from yeast to hu-
man beings (Sims and Wiedmer, 2001). Human Scramblase 1 
(PLSCR1) was initially identifi  ed as a protein thought to be 
  involved in facilitation of transbilayer movement of phos-
pholipids across the plasma membrane (Basse et al., 1996; 
Comfurius et al., 1996; Zhou et al., 1997). Many cell mem-
branes harbor a Ca
2+-dependent mechanism that can facilitate 
transbilayer movement of phospholipids between the two leaf-
lets, leading to loss of membrane lipid asymmetry termed 
scrambling. Scrambling is observed in platelets, erythrocytes, 
and other cells after elevated intracellular Ca
2+ and cell injury 
by complement and also in cells undergoing phagocytosis and 
apoptosis (Zwaal et al., 2005). Attempts to purify and clone 
proteins active in scrambling led to the identifi  cation of human 
PLSCR1. Scramblases are type 2 single-pass transmembrane 
proteins (Zhou et al., 1997). The four members identifi  ed in 
mice and humans have been named PLSCR1 through -4. All 
except PLSCR2 contain a proline-rich NH2-terminal domain 
with PXXP and PPXX motifs that can potentially bind to SH3 
and WD40 domain–containing proteins. An intracellular EF 
hand, a Ca
2+ binding motif, precedes the transmembrane 
  segment. Mice lacking two of these Scramblases, 1 and 3, were 
recently generated. Cells derived from PLSCR1-null mice 
showed alterations in granulocyte production in response to 
growth factors and antiviral response to interferon (Zhou et al., 
2002). PLSCR3-null mice and double mutants of PLSCR1 and -3 
nulls showed adiposity, dyslipidemia, and insulin resistance 
(Wiedmer et al., 2004). Neither of the knockout mice shows 
defects in events associated with lipid scrambling. This sug-
gests either that the other two members of the PLSCR family 
maintain Scramblase activity or that the presumed activity of 
this protein in scrambling is incorrect. Hence, the actual in vivo 
biological function of members of the Scramblase family has 
yet to be elucidated.
The Drosophila melanogaster genome encodes two ubiq-
uitously expressed proteins with strong sequence homology to 
mice and human Scramblases. Using a reverse genetic approach, 
we have generated fl  ies lacking each of the two Scramblases 
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cramblases are a family of single-pass plasma 
membrane proteins, identiﬁ  ed by their purported 
ability to scramble phospholipids across the two 
layers of plasma membrane isolated from platelets and 
red blood cells. However, their true in vivo role has yet 
to be elucidated. We report the generation and isolation 
of null mutants of two Scramblases identiﬁ  ed  in  Dro-
sophila melanogaster. We demonstrate that ﬂ  ies lacking 
either or both of these Scramblases are not compromised 
in vivo in processes requiring scrambling of phospho  lipids. 
Instead, we show that D. melanogaster lacking both 
Scramblases have more vesicles and display enhanced 
recruitment from a reserve pool of vesicles and increased 
neurotransmitter secretion at the larval neuromuscular 
synapses. These defects are corrected by the introduc-
tion of a genomic copy of the Scramb 1 gene. The lack 
of phenotypes related to failure of scrambling and 
the neurophysiological analysis lead us to propose that 
Scramblases play a modulatory role in the process 
of neurotransmission.
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  individually and fl  ies lacking both Scramblases. Our studies us-
ing these mutants indicate that Scramblases do not play a deter-
ministic role in scrambling of phospholipids that accompanies 
developmentally regulated apoptosis or in immune response 
  involving phagocytosis of bacterially infected cells. Further 
analyses indicate that Scramblases play a modulatory role in 
the process of neurotransmission at the larval neuromuscular 
 junction  (NMJ).
Results
D. melanogaster Scramblases
The deduced sequences of the mammalian PLSCR family of 
proteins reveal them to be type 2 plasma membrane proteins 
with the transmembrane domain at the COOH terminus and 
a proline- and cysteine-rich acidic domain. The NH2-terminal 
segments contain PXXP and PPXY sequences that are potential 
SH3 and WW domain binding sites, respectively. The COOH-
terminal ends of the proteins are conserved and contain a puta-
tive Ca
2+ binding motif proximal to the transmembrane domain. 
There is considerable sequence variation at the NH2-terminal 
segment of Scramblases. The PLSCR2 member of the family 
lacks the NH2-terminal proline- and cysteine-rich sequence. 
D. melanogaster genome analysis identifi  es two genes with sig-
nifi  cant homology to mammalian Scramblases (Fig. 1 A; Drysdale 
et al., 2005). These are CG32056 and CG1893. Protein encoded 
by CG32056 Scramb 1 shows 37% identity with mouse Scramb 1 
(PLSCR1) protein, whereas that of CG1893 or Scramb 2 pro-
tein shows 41% identity with Scramb 2 (PLSCR2). The Scramb 1 
and 2 proteins of D. melanogaster are 56% identical and 69% 
similar to each other (Fig. 1 A). Although Scramb 1 includes the 
proline-rich region NH2-terminal domains with PXXP and 
PPXX motifs that bind SH3 and WD40 region, Scramb 2 pro-
tein lacks this stretch of amino acids and in this regard is closer 
to mammalian Scramb 2 protein. A third gene, CG9804, has 
been labeled as Scramblase in the annotated genome. However, 
this protein shows only 25% identity with either mammalian or 
the D. melanogaster Scramblases and seems to have branched 
out earlier during evolution. Moreover, unlike the other two 
D. melanogaster proteins, this protein has restricted expression, 
as we fail to see ubiquitous expression by Western analysis 
 (unpublished data). CG10427 stated as a Scramblase in the Flybase 
was annotated as an uncertain gene and has been eliminated in 
release 3 of the genome annotation (this aberration resulted 
from annotation errors of CG32056 gene region).
To profi   le the tissue and developmental expression of 
Scramblases in D. melanogaster, we have generated polyclonal 
antibodies against both Scramb 1 and 2 proteins and in addition 
have obtained monoclonal antibodies against Scramb 1 protein. 
We have also succeeded in expressing a GFP-tagged version of 
Scramb 2 using the upstream activating sequence (UAS)–Gal4 
system (Brand and Perrimon, 1993). Western blot analysis of 
wild-type D. melanogaster demonstrates that the two proteins 
are expressed ubiquitously and throughout development (Fig. 
1 B). Lower levels are observed by Western analysis in early 
embryos before cellularization. The low abundance in early 
embryos is attributable to the fact that these are predomi  nantly 
plasma membrane proteins (see below and Fig. S1, avail  able 
at http://www.jcb.org/cgi/content/full/jcb.200506159/DC1). 
The  D. melanogaster embryo begins as a single cell and a 
syncitium before undergoing cellularization, and the plasma 
membrane surface grows  30-fold during cellularization of 
the syncytial embryo. Immunofl   uorescence localization and 
analysis of transgenic fl  ies (GFP–Scramb 2 fusion) localize the 
proteins   predominantly to the plasma membrane (not depicted). 
We have colocalized Scramb 1 protein with HRP antigen at the 
plasma membrane in the larval neurons and the Scramb 2 pro-
tein with Notch that localizes to the plasma membrane at the 
apical margins of the cells of the larval eye-antennal anlagen 
(Fig. S1). Although Scramb 2 is homogeneously localized at the 
plasma membrane, Scramb 1 shows a nonhomogenous distri-
bution along the plasma membrane, with areas of intense stain-
ing interspersed with areas of homogenously strong staining. 
The localization of the two proteins suggests a role for them in 
Figure 1.  Scramblases are evolutionarily conserved and ubiquitously expressed. (A) Comparison of the amino acid sequences of Saccharomyces 
cerevisiae Scramblase homologue, Yjr100cp, D. melanogaster Scramb 1 and 2 (DmScramb 1 and 2), and human Scramblases 1–4 (HsPLSCR1-4) 
  proteins using multiple sequence alignment and box shade programs. (B) Extracts were prepared from D. melanogaster during various stages of devel-
opment as indicated, and 5 μg of extracts were loaded on gel and probed for Scramb 1 and 2 protein as indicated. Blots were reprobed for tubulin 
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events involving the plasma membrane. Because the in vivo 
role of Scramblases in lipid scrambling and other cellular 
  functions remains unresolved, we decided to generate mutant 
fl  ies lacking the family of Scramblases and then carry out func-
tional analyses.
Generation and isolation 
of Scramblase mutants
We have used a Western blot–based reverse genetics approach 
to obtain mutants for both Scramblase genes in D. melanogaster 
(Dolph et al., 1993; Acharya et al., 1998). The lack of predict-
able phenotypes defi  ning the mutant complicates many genetic 
screens. Therefore, we used a previously documented Western 
blot–based screening strategy that monitors loss of protein ex-
pression (loss of Scramblase expression in our case) on immuno-
blots (Dolph et al., 1993; Acharya et al., 1998). In this protocol, 
male fl   ies are randomly mutagenized, by feeding them the 
chemical mutagen, ethyl methane sulfonate (EMS). Muta-
genized males are crossed to female balancer fl  ies. Balanced 
progeny are crossed to fl  ies with a large chromosomal defi  -
ciency that uncovers the genomic interval including the Scramb 1 
gene. Single heads from fl  ies trans-heterozygous for the defi  -
ciency and a mutagenized third chromosome are screened for 
the loss of Scramb 1 antigen by Western blots (Fig. 2 A). From 
a screen of 1,950 EMS-mutagenized third chromosomes, 1,900 
lines that were viable in trans to Df(3L)AC1, 
rnroe-1p
p were 
  obtained. Western analysis of these lines identifi  ed a mutant line 
expressing no Scramb 1 protein (Fig. 2 A, bottom). The Scramb 1 
gene was isolated from this mutant and subjected to sequence 
analysis. The scramb1-null mutant had a T-to-A transition in the 
fi  rst intron of the coding region. This leads to a splicing defect 
(confi  rmed by RT-PCR across intron 1) and truncation of the 
protein after 38 amino acids (+ 3 amino acids of the intron). 
Thus, the scramb1 mutant is either a null allele or a severely 
 hypomorphic  mutant.
Likewise, in the Scramb 2 screen, 2,100 lines, viable in 
trans over Df(3L)M21(kni[ri-1]p) were established and screened 
by Western analysis (Fig. 2 B, top). One of the lines showed no 
antigen reactivity against the Scramb 2 antibody (Fig. 2 B, 
 bottom). Sequencing of the Scramb 2 gene from this line showed 
a T-to-A transition at the fi  rst exon–intron junction. In this 
  instance, the splicing defect (confi  rmed by RT-PCR) leads to 
termination of the gene after 57 amino acids (an additional eight 
amino acids from read-through in the intron). Hence, the 
scramb2 mutant is either a null or severely hypomorphic   mutant. 
Both mutants were backcrossed three times to w1118 (control) 
to outcross all background mutations.
The two mutants are null (or severely hypomorphic) for 
the respective normal Scramblase proteins. Double mutants of 
scramb1 and -2 were generated by meiotic recombination of the 
individual mutants. The double mutants do not express both 
proteins as confi  rmed by Western analysis and also by immu  no-
fl  uorescence at the larval NMJ (Fig. 2 and Fig. S2, available
at http://www.jcb.org/cgi/content/full/jcb.200506159/DC1).
Because the in vivo role of Scramblases in lipid scrambling has 
not been unequivocally established, we analyzed the mutants 
in events requiring scrambling of phospholipids, including the 
  exposure of phosphatidylserine (PS) on cell surface in cells 
  undergoing apoptosis and phagocytosis.
Scramblase mutants show no defects 
in developmentally regulated and ectopically 
induced apoptotic events in vivo
scramb1,  scramb2, and the double mutants are homozy-
gous   viable. Programmed cell death is an important feature 
of  D. melanogaster development and tissue homeostasis. 
Figure 2.  Generation and isolation of Scramblase mutants. (A) The genetic scheme to isolate the scramb1 mutant. (B) The scheme to obtain mutants in 
Scramb 2. The Western blot analysis of the null mutants is shown below the schemes. For scramb1, analysis of 1, 2, and 3 head extracts were loaded and 
probed. The blot was probed for D. melanogaster ceramidase (CDase) as loading control (Acharya et al., 2003, 2004). In the blot for scramb2-null mutant 
analysis, 1, 5, and 10 head worth of extracts from control w1118 and the mutant were loaded and probed for the protein. The blots were probed for 
  Inositol polyphosphate 1-phosphatase (IPP) as loading control (Acharya et al., 1998).JCB • VOLUME 173 • NUMBER 1 • 2006  72
During development, excess cells and tissues that are no longer 
useful are removed by apoptosis, and mutants that fail to un-
dergo such normal apoptosis do not survive past embryogenesis 
(White et al., 1994). Because Scramblase mutants are viable 
and fertile and show no developmental defects, apoptosis dur-
ing development is clearly not compromised in these mutant 
fl  ies. As in mammals, apoptotic cell death in D. melanogaster is 
also characterized by PS exposure and clearance of cells by 
phagocytosis (van den Eijnde et al., 1998). In D. melanogaster, 
reaper, hid, and grim genes are necessary for induction of apop-
tosis.   Ectopic overexpression of any of these genes in the fl  y eye 
using the eye-specifi  c driver GMR (glass multimer reporter) 
causes   normal photoreceptors to undergo apoptotic cell death, 
resulting in a severe eye ablation phenotype (Nordstrom et al., 
1996). To determine whether Scramblase mutants can modulate 
this phenotype, we examined eyes from fl  ies overexpressing 
reaper in each of the three mutant backgrounds. The eye sizes 
were not signifi  cantly different in the three mutant backgrounds 
compared with control fl  ies (Fig. 3). This indicates that the dy-
namics of reaper-mediated apoptotic cell death is not altered in 
Scramblase mutant backgrounds. Because the eye sizes were 
not different between the control w1118 and mutant fl  ies, PS-
mediated cell death and phagocytic clearance of apoptotic cells 
were clearly unaffected in the mutant backgrounds. Thus, 
Scramblases are not required for either programmed or ectopi-
cally triggered apoptotic cell death.
Scramblase mutants can mount 
an effective response to infection 
with microorganisms
Immune defense mechanisms in D. melanogaster, like in other 
metazoan organisms, include physical barriers to infection, 
  innate, and humoral responses (Lavine and Strand, 2002; 
  Hoffmann, 2003; Brennan and Anderson, 2004; Leclerc and 
Reichhart, 2004). The immune hemocyte cells, for example, 
  mediate cellular responses such as phagocytosis, encapsulation, 
and melanization, as well as produce humoral effector proteins. 
Phagocytic cells recognize a variety of signals on cells primed 
for phagocytosis (such as apoptotic and bacterially infected 
cells), including cell surface exposure of PS. We decided to eval-
uate whether the absence of Scramblases compromised any of 
these functions, resulting in an observable phenotype. We there-
fore infected wild-type and mutant cells with a mixture of gram 
positive and negative microorganisms as described in   Materials 
and methods (Rodriguez et al., 1996; Bernal and Kimbrell, 
2000). Immune competence is measured as viability of fl  ies over 
time, as shown in Table I. The resistance to an inoculum of mixed 
microorganisms was comparable between the control w1118 and 
mutant backgrounds. Thus, the immune competence of Scram-
blase mutants is similar to wild-type fl  ies and not compromised.
We conclude that Scramblases do not play a critical role 
in in vivo events that involve scrambling of phospholipids, such 
as exposure of PS to the outer leafl   et and immunoreactive 
mechanisms for phagocytic clearance of bacterially infected 
cells. To demonstrate that PS exposure, a process requiring 
scrambling of phospholipids, was not compromised in back-
grounds where Scramblase protein levels are perturbed, we 
conducted a series of experiments using D. melanogaster 
  Schneider (S2) cells in which we either overexpressed the two 
Scramblases or depleted them using RNAi.
Increased expression or knock down 
of Scramblases in S2 cells does not 
affect PS exposure on cell surface
Exposure of cell surface PS during apoptosis has been used as a 
measure of the ability of cells to scramble phospholipids (Schlegel 
et al., 2000; Tepper et al., 2000; Wolfs et al., 2005). An early 
event in apoptosis is exposure of PS on the cell surface, which 
can be analyzed by binding of fl  uorescently labeled annexin V 
Figure 3.  Scramblase mutants can undergo apoptotic cell death and 
mount an effective immune response. Two copies of reaper were expressed 
under the control of GMR promoter. Expression of reaper results in apop-
totic cell death of photoreceptors. Expression in scramb1, scramb2, or the 
double mutant did not affect reaper-induced apoptosis.
Table I. Survival after infection with mixed microorganisms
Days after infection Percentage of ﬂ  ies surviving (± SD)
w1118 scramb1 scramb2 Double mutant
1 88 ± 5.6 82 ± 5.5 82 ± 8.1 82 ± 3.2
2 69 ± 7.1 67 ± 7.2 62 ± 4.9 63 ± 7.0
3 52 ± 2.1 55 ± 1.5 50 ± 7.6 50 ± 4.2
4 43 ± 3.6 46 ± 4.2 46 ± 5.6 45 ± 4.0
3-d-old control w1118, scramb1, scramb2, and the double-mutant ﬂ  ies were individually infected with a mixed microorganism culture, as described in Materials and methods. 
After the ﬂ  ies recovered from the effects of anesthesia, they were set up in vials in groups of 10 and observed over the next 2 wk, and percentage of survival was 
calculated. Because the mortality was not affected 4 d after infection in all the samples studied, only data for 4 d after infection has been included.SCRAMBLASES MODULATE REGULATED EXOCYTOSIS • ACHARYA ET AL. 73
that has a high affi  nity for cell surface PS. The impermeant 
  nucleic acid dye propidium iodide is used in conjunction to ex-
clude cells whose plasma membrane integrity is compromised 
(necrotic or damaged). To visualize the process of scrambling 
(i.e., exposure of PS in cells with altered Scramblase expres-
sion), we used D. melanogaster S2 cells to knock down or over-
express Scramblase and follow PS exposure. Scramb 1 and 2 
proteins were knocked down separately or together by RNAi 
treatment in S2 cells by transfecting with double-stranded RNA 
(dsRNA) as described in Materials and methods. Western blot 
analysis of dsRNA-treated cell lysates (+) shows signifi  cant 
depletion of Scramb 1 and 2 compared with untreated lysates 
(Fig. 4, A and B). S2 cells after dsRNA treatment were incu-
bated in a Ca
2+-rich medium containing fl  uorescently labeled 
annexin V and propidium iodide. PS exposure was measured as 
percentage of cells that stained positive for annexin V but nega-
tive for propidium iodide (Fig. 4 D, % scrambling). As seen in 
Fig. 4 D (–Act D), there is no difference between control S2 
cells and Scramb 1, Scramb 2, and the double (Scramb 1, 
Scramb 2) knockdown cells. We then tested whether scrambling 
would be compromised in Scramblase knockdown cells under-
going apoptosis. It has previously been shown that D. melano-
gaster S2 cells undergo apoptosis and expose PS when treated 
with Actinomycin D (Zimmermann et al., 2002). Using similar 
conditions, apoptosis was induced in S2 cells by Actinomycin D 
treatment, and PS exposure was measured as before. There were 
no apparent differences in the ability of these cells to   expose 
their cell surface PS (Fig. 4 D, +Act D) as compared with non-
RNAi–treated cells undergoing apoptosis.
We then stably overexpressed Scramb 1 and 2 proteins under 
the control of the metallothionein promoter (Bunch et al., 1988). 
Fig. 4 C depicts Western blots showing dramatic inducible 
expression of both Scramblases. PS exposure was measured in 
these cells overexpressing Scramblases. There was no signifi  cant 
difference in the number of cells that were annexin V positive 
and propidium iodide negative between the control and over-
expressors (Fig. 4 E, % scrambling). The baseline apoptosis 
was itself slightly higher, probably because of the addition of 
0.5 mM copper sulfate to induce protein expression (Fig. 4 E, 
−Act D). Next, we induced apoptosis in S2 cells overexpressing 
Scramb 1 or 2 protein by Actinomycin D treatment and evaluated 
PS exposure by annexin V binding assays. There was no differ-
ence between the vector-transfected control and the overexpress-
ing stable cells (Fig. 4 E, +Act D). Thus, neither knock down or 
overexpression of Scramblases resulted in altered exposure of 
PS in resting cells as well as in cells undergoing apoptosis.
The results described above lead us to believe that Scram-
blases do not play a determining role in scrambling of phospho-
lipids in D. melanogaster. We then sought to evaluate the actual 
in vivo functions of this family of proteins. The Scramblase 
double-mutant fl  ies appear visibly more active in a vial compared 
with either of the single mutants or the control w1118 fl  ies. 
  Hyperactivity has been associated with neurological alterations 
in D. melanogaster (Wang et al., 1997; Ghezzi et al., 2004). 
  Because the double mutants were hyperactive and because 
Scramblases are ubiquitously expressed in the plasma mem-
brane, the D. melanogaster NMJ was analyzed in our mutant 
for defects in synaptic structure and function. D. melanogaster 
larval NMJ is extremely active with intracellular and intercellular 
 signaling   involving  a plethora of signal-transduction cascades 
  active across plasma membranes at the junction (Keshishian 
et al., 1996; Rodesch and Broadie, 2000; Keshishian, 2002; 
Kidokoro et al., 2004; Kuromi and Kidokoro, 2005). We ratio-
nalized that the structure and function would be sensitive to loss 
Figure 4.  Scramblase proteins are not involved in cell surface exposure of PS. (A) S2 cells were transfected with Scramb 1 or 2 dsRNA, and cells were har-
vested 24 and 48 h after transfection and analyzed by Western analysis for Scramb 1 or 2 protein. Both Scramb 1 and 2 are down-regulated tremendously by 
RNAi-mediated knockdown. The extracts were probed for tubulin as loading controls. (B) Both Scramb 1 and 2 were knocked down in S2 cells simultaneously, 
and cells were assayed for protein 48 h after transfection. Both proteins are down-regulated in this experiment. (C) Stable cell lines overexpressing Scramb 1 or 2 
proteins under the control of a metallothionein promoter were established. Both proteins are massively expressed upon induction in these cells. The extracts were 
probed for tubulin as controls. (D and E) The percentage of cells that stain positively for annexin V binding and negatively for propidium iodide were counted 
and plotted as percentage of scrambling. (D) Annexin V–positive cells in those that have undergone RNAi-mediated knockdown. (E) Scramblase overexpressing 
cells. RNAi-mediated knockdown cells were subject to 3 μM Actinomycin D for 3 h, and the percentage of scrambling cells was determined (D; +Act D column). 
As the baseline percentage of apoptotic cells was slightly higher in cells overexpressing Scramblase (E; −Act D column; probably due to the addition of 1 mM 
copper sulfate to induce protein), 2 μM Actinomycin D was used and the percentage of scrambling calculated (E; +Act D column).JCB • VOLUME 173 • NUMBER 1 • 2006  74
of Scramblase proteins if they had an important role in events 
involving the plasma membrane.
Scramblase mutants show altered 
synaptic function and increased release 
of neurotransmitters
We verifi  ed the expression of Scramb 1 and 2 at the larval NMJs 
by immunofl  uorescence colocalization with synaptotagmin and 
HRP (Fig. 5). We also performed coimmunolocalization of 
Scramb 2 with disc large, cysteine string protein, syntaxin, and 
Fasciclin II (Fig. S4, available at http://www.jcb.org/cgi/content/
full/jcb.200506159/DC1). Scramb 1 and 2 proteins are expres-
sed in all segmental nerves and presynaptic and postsynaptic 
  membranes of the larval NMJs (Figs. 5, S3, and S4). We then 
undertook ultrastructural examination and analysis of the active 
zones (Babcock et al., 2004; Rohrbough et al., 2004). The anal-
ysis revealed a signifi  cant increase in the number of synaptic 
vesicles (SVs) and more vesicles docked at the active one (Fig. 6 
and Table II). The single mutants, on the other hand, did not 
show signifi  cant changes in the ultrastructure of NMJs, except 
that there was more than one docked vesicle at the active zone 
of most of the type 1b boutons examined (unpublished data).
We reasoned that an increased SV content in double-mutant 
synapse shown in EM studies should result in an increased 
  loading of FM1-43 at nerve endings after massive vesicle mobi-
lization. FM1-43 binds to membranes and remains trapped in 
SVs that undergo endocytosis. We analyzed the extent of FM1-43 
loading in vesicles cycling through an exo/endo pool of SVs 
(ECP). Loading of ECP with FM1-43 was achieved by exposing 
boutons (5 min) to an external solution high in K
+ in the pres-
ence of dye (Fig. 7 A; Delgado et al., 2000). Fluorescence bright-
ness was analyzed 5 min after extensive perfusion with dye-free 
standard solution. Data analysis revealed that fl  uorescence 
brightness in double-mutant boutons was signifi  cantly above 
control (Fig. 7 A). After ECP loading, we subjected synapses to 
high-frequency stimulation of the nerve at 10 Hz in a standard 
external solution containing FM1-43, to also load vesicles cy-
cling through a reserve pool (RP) of SVs. As shown in Fig. 7 B, 
this maneuver increases dye load, and fl  uorescence now distrib-
utes over the whole volume of synaptic boutons. Under these 
conditions also, fl  uorescence brightness in the   double mutant 
was signifi  cantly above control (Fig. 7 B). Finally, to evaluate the 
extent of dye loading in SVs cycling through RP, synapses were 
exposed for a second round to a high K
+ solution void of dye 
(3 min) to induce massive release of SVs in ECP. The fl  uorescence
that remains after this second  exposure to high K
+ labels vesicles 
that are cycling through the RP (Delgado et al., 2000). Data anal-
ysis revealed that fl  uorescence brightness was signifi  cantly larger 
in double-mutant   boutons (Fig. 7 C). Thus, our FM1-43–loading 
studies are   consistent with EM data indicating an excess content 
of SVs in double-mutant presynaptic terminals. Importantly, as 
documented in Fig. 7, in all conditions, the extent of FM1-43 
loading in the double mutant was rescued to control values by 
the introduction of a copy of the Scramb 1 gene.
Figure 5.  Scramblase proteins localize to the 
larval NMJs.  The Scramblase proteins were 
  localized by anti–Scramb 1 monoclonal 
(A and G) and rabbit anti–Scramb 2 poly-
clonal antibodies. Rabbit anti-synaptotagmin 
(B) or monoclonal (E) and anti-HRP (H and K) 
were used in coimmunolocalization. The over-
lays are shown in C, F, I, and L.SCRAMBLASES MODULATE REGULATED EXOCYTOSIS • ACHARYA ET AL. 75
We then proceeded to investigate ECP exocytosis rate by 
monitoring the decay of FM1-4 fl  uorescence brightness after 
dye loading of vesicles through ECP during low-frequency 
stimulation of the nerve at 0.5 Hz. Under this condition, trans-
mitter release is maintained essentially by mobilization of ECP 
(Kuromi and Kidokoro, 2000). We found that the time course of 
decline of fl  uorescence brightness was similar in double-mutant 
and control boutons, indicating similar properties of ECP exo-
cytosis (unpublished data). We also investigated the recruitment 
of SVs from an RP. The RP contains a majority of SVs and has 
been implicated in use-dependent increase in transmitter release 
and is mobilized during high-frequency activity at the synapse 
(Delgado et al., 2000; Kuromi and Kidokoro, 2000). 5 min after 
dye loading of SVs cycling through the RP, RP recruitment 
rates were assessed by monitoring the decline in fl  uorescence 
brightness during high-frequency stimulation at 10 Hz. We 
found that the rate of RP recruitment was markedly enhanced in 
double-mutant boutons, as indicated by a signifi  cantly faster rate 
of fl  uorescence brightness decline (2.4 ± 0.2 min [n = 10] vs. 
8.5 ± 0.3 min [n = 10]; Fig. 7 D). This result prompted us to 
investigate whether RP recruitment at rest, in the absence of 
high-frequency stimulation of the nerve, was also enhanced in 
the double mutant. Therefore, we evaluated the extent of fl  uo-
rescence brightness decline at rest, 5 min after SVs cycling 
through RP were loaded with dye. As shown in Fig. 7 E (top) at 
rest, the decline in fl  uorescence brightness was markedly en-
hanced in double-mutant boutons (fi  vefold). Moreover, the ex-
tent of fl  uorescence decline induced by a 5-min stimulation of 
the nerve at 0.5 Hz in the double mutant was also signifi  cantly 
enhanced relative to control (Fig. 7 E, bottom). These results 
  reveal that RP recruitment in double-mutant synapses is abnor-
mally enhanced. Fig. 7 (D and E) also documents that RP 
recruitment in double-mutant larvae was rescued to control lev-
els by the introduction of a copy of the Scramb 1 gene.
We next evaluated the properties of synaptic transmission by 
recording nerve-evoked postsynaptic currents from larval NMJs 
(Acharya et al., 1998; Delgado et al., 2000; Kidokoro et al., 
2004). Single-mutant synapses displayed transmitter release and 
plasticity properties that did not differ signifi  cantly from control 
(unpublished data). In contrast, synaptic transmission in the dou-
ble mutant differed in several aspects from the control. We fi  rst 
observed that the frequency of spontaneous postsynaptic cur-
rents was signifi  cantly enhanced in the double mutant (Table III). 
We also found that release probability, quantal   content, and 
nerve-evoked postsynaptic currents were signifi  cantly larger in 
the double mutant (Fig. 8, A and C; and Table III). On the other 
hand, the amplitude of current and the charge transferred by the 
release of a single quantum were, within   experimental error, the 
same in control and double mutant (Table III). Fig. 8 A shows 
plots of nerve-evoked postsynaptic currents as a function of 
 external  Ca
2+ concentration in double logarithmic fashion in 
control, double mutant, and P{Scramb 1};   double mutant. Data 
analysis revealed a similar Ca
2+ cooperativity   coeffi  cient for 
nerve-evoked responses. However, in double-mutant synapses, 
the curve was shifted toward lower Ca
2+ concentrations. We also 
recorded postsynaptic currents evoked by exposing synapses to a 
Figure 6.  Scramblase mutants have an increased number of SVs in the 
active zone. (top) Transmission electron micrograph of a synaptic bouton 
from control w1118 and the double mutant. (middle) Transmission EM 
comparison of the active zones from a control w1118 and the double 
  mutant. The arrows indicate the T-bar in the active zone. Arrowheads show 
the vesicles clustered close to this area. (bottom) The top two ﬁ  gures show 
the active zones from w1118 type 1b synaptic boutons, and the bottom 
two ﬁ  gures are from the double mutants.
Table II. Comparison of SV distribution in the boutons, including 
around the active zones of control and double-mutant NMJs
Description W1118 Double mutant
Number of vesicles 37.7 ± 1.1 60.7 ± 3.3
Cross-section (μM) 1.3 ± 0.1 1.2 ± 0.1
Clustered (<0.25 μM) 10.7 ± 1.1 25.2 ± 1.7
Docked 1.3 ± 0.3 4.1 ± 0.5
Nonclustered 27.0 ± 1.6 34.8 ± 2JCB • VOLUME 173 • NUMBER 1 • 2006  76
Figure 7.  FM1-43 imaging. Studies of FM1-43 loading were made using the same FM1-43 stock, and the dye concentration was 5 μM. Data shown in 
graphs was derived from 25 boutons from 10 different larvae ± SEM. In all cases, ﬂ  uorescence brightness was measured 3 min after extensive perfusion 
with a dye-free solution. (A) Studies of FM1-43 loading of ECP. Images are representative examples of dye-loading patterns in w1118, double mutant, and 
P{Scramb 1}; double mutant synaptic boutons. The graph below offers mean values of ﬂ  uorescence brightness in w1118, double mutant, and P{Scramb 1}; 
double mutant synaptic boutons. (B) Studies of FM1-43 loading of SVs cycling through ECP and RP. Images are representative examples obtained in 
w1118, double mutant, and P{Scramb 1}; double mutant. Graph shows mean ﬂ  uorescence brightness values ± SEM in w1118, double mutant, and 
P{Scramb 1}; double mutant. (C) Studies of dye loading of SVs cycling through RP. Images are representative examples of dye-loading patterns of SVs 
  cycling through RP, and the graph shows mean ﬂ  uorescence brightness values ± SEM. A t test revealed that in all cases differences in ﬂ  uorescence bright-
ness between double mutant, w1118, and P{Scramb 1}; double mutant are signiﬁ  cant (P < 0.05). In all conditions, ﬂ  uorescence brightness in control and 
P{Scramb 1}; double mutant was not statistically different. (D) Enhanced RP recruitment in double-mutant synapses and rescue in P{Scramb 1}; double mu-
tant during high-frequency stimulation of the nerve. After dye loading of SVs cycling through RP was achieved using protocol explained in C, the time course 
of RP recruitment was evaluated by following the decline in ﬂ  uorescence brightness during tetanic nerve stimulation at 10 Hz. The images above the graph 
show patterns of FM1-43 ﬂ  uorescence at t = 0 and after 8 min of nerve stimulation at 10 Hz. Lines joining experimental points in graph are best ﬁ  ts to single 
exponential functions with time constants of 2.4 ± 0.2 min (double mutant) and 8.5 ± 0.2 min in control and P{Scramb 1}; double mutant. (E, top) 
  Enhanced RP recruitment at rest, in the absence of high-frequency stimulation, in double mutant and rescue in P{Scramb 1}; double mutant. (bottom) 
  Enhanced RP recruitment in double mutant during low-frequency stimulation (5 min) at 0.5 Hz in double mutant and rescue in P{Scramb 1}; double mutant. 
The extent of RP recruitment was evaluated 5 min after SVs cycling through the RP were loaded with FM1-43. Mean values of relative ﬂ  uorescence bright-
ness were derived from at least 10 different boutons from ﬁ  ve different larvae. Bars, 5 μm.SCRAMBLASES MODULATE REGULATED EXOCYTOSIS • ACHARYA ET AL. 77
hyperosmotic 0.5 M sucrose solution (Acharya et al., 1998). 
As documented in Fig. 8 B, neurotransmitter release evoked by 
  application of a 20-s hyperosmotic shock in the vicinity of the 
synapse was dramatically increased in the double mutant. Impor-
tantly, as documented in Fig. 8 and Table III, the synaptic defects 
in the double mutant were rescued by the introduction of a copy 
of the Scramb 1 gene.
In further studies, we investigated plasticity properties of 
double-mutant synapses. Analysis of paired-pulse facilitation 
revealed that although the extent of facilitation of neurotrans-
mitter release in the double mutant was diminished relative to 
the control, this difference was not signifi  cantly different from 
the control (Table III). We next evaluated tetanic facilitation and 
posttetanic potentiation (PTP) by monitoring nerve-evoked cur-
rents using a stimulation protocol designed to monitor tetanic 
facilitation and PTP. Postsynaptic responses were evoked fi  rst 
by stimulating the nerve at 0.5 Hz for 20 s. This was followed 
by a period of tetanic stimulation at 10 Hz for 50 s. After the 
  tetanic stimulation, the regimen was switched back to 0.5 Hz 
to monitor PTP. We found that the extent of facilitation of 
Figure 8.  Abnormal properties of transmit-
ter release in the double mutant and rescue 
in P{Scramb 1}; double mutant larval neuro-
muscular synapses. (A) Ca
2+ dependence of 
transmitter release. Straight lines joining ex-
perimental points were built, with mean slope 
values derived from ﬁ   ve different studies. 
(B) Studies of osmotic release of neurotrans-
mitter. Records are representative examples 
of postsynaptic currents evoked by application 
of hyperosmotic solution, illustrating enlarged 
responses in double mutant and rescue in 
P{Scramb 1}; double mutant. The graph shows 
mean values of quantal content of currents 
evoked, estimated by dividing the integral of 
charge transferred during hyperosmotic shock 
divided by the integral of charge transferred by 
release of single quanta. Graph show means of 
six different studies ± SEM. Quantal content in 
double mutant was signiﬁ  cantly above control 
and P{Scramb 1}; double   mutant (P < 0.05). 
Within experimental error, quantal content of 
postsynaptic currents evoked by hyperosmotic 
shock was the same in control and P{Scramb 1}; 
double mutant. (C) Tetanic facilitation and PTP 
induced by high-frequency stimulation of the 
nerve at 10 Hz. The re  cordings document 
enlarged nerve-evoked responses in double 
mutant and rescue of responses in P{Scramb 1}; 
double mutant and are representative of post-
synaptic currents evoked during application of the protocol used to monitor tetanic facilitation and PTP. The graphs are mean quantal content of nerve-
evoked currents during paradigm to monitor tetanic facilitation and PTP. Single arrows indicate the moment at which frequency of stimulation was switched 
from 0.5 to 10 Hz, leading to an increase in transmitter release (tetanic facilitation). Double arrows signal the moment at which stimulating frequency was 
switched back to 0.5 Hz. The discontinuous lines in the plots indicate quantal content of evoked currents before application of   tetanic stimulation. Points in 
plot are means of at least seven different studies. Error bars were excluded for clarity.
Table III. Comparison of characteristics of spontaneous response, quantal content, and evoked responses from w1118 control 
and the double-mutant larval NMJs
Parameter w1118 Double mutant P{Scramb 1}; Double mutant
Quantal content (m) 0.35 ± 0.07 (9) 0.74 ± 0.14 (6)  0.32 ± 0.07 (5)
Release probability (pr) 0.29 ± 0.05 (9) 0.51 ± 0.06 (6)  0.27 ± 0.05 (5)
Frequency of spontaneous currents (Hz)    2.76 ± 0.51 (14)    5.61 ± 0.97 (20)   2.82 ± 0.44 (5)
Integral of current evoked by release of a single 
 quanta  (pC)
16.00 ± 0.41 (3) 16.46 ± 0.36 (3)  16.16 ± 0.28 (3)
Ca
2+ cooperativity coefﬁ  cient of nerve-evoked currents   3.40 ± 0.07 (5) 3.36 ± 0.12 (5)   3.47 ± 0.19 (4)
Amplitude of current evoked at 0.5 Hz (nA)    25.90 ± 3.66 (12) 41.64 ± 3.66 (11)    24.35 ± 3.93 (11) 
Paired-pulse facilitation      1.41 ± 0.09 (27)   1.25 ± 0.14 (20)    1.45 ± 0.28 (8)
Tetanic facilitation      1.94 ± 0.19 (12)   1.68 ± 0.07 (12)    1.91 ± 0.23 (8)
Quantal content, probability of releasing at least one quanta, and frequency of spontaneous postsynaptic currents were monitored and estimated as described 
previously (Acharya et al., 1998) in a standard working solution containing 75 μM, under conditions at which release probability is low. Also, quantal and charge 
transferred by release of a single quanta were studied as described previously (Acharya et al., 1998; Delgado et al., 2000). Paired-pulse facilitation was deﬁ  ned as 
the ratio of the amplitude of the postsynaptic currents evoked by two consecutive stimulating episodes separated by 100 ms. Tetanic facilitation was taken as the ratio 
of amplitudes of last and ﬁ  rst currents evoked by a 50-s tetanic stimulation at 10 Hz.JCB • VOLUME 173 • NUMBER 1 • 2006  78
  transmitter release elicited by high-frequency stimulation of the 
nerve did not differ signifi  cantly from the control (Table III). On 
the other hand, we observed that PTP in the double mutant was 
abnormally prolonged. As shown in Fig. 8 C, in control syn-
apse, nerve-evoked transmitter release decayed to values before 
stimulation (Fig. 8 C, bottom, discontinuous line) in  50 s after 
the cessation of high-frequency stimulation. In contrast, in the 
double mutant, transmitter release remained signifi  cantly po-
tentiated after 100 s, indicating altered short-term synaptic 
memory. Introduction of a genomic copy of the Scramb 1 gene 
in the double mutant rescued PTP to normal. Also expression of 
a UAS–Scramb 2 gene driven by elav-GAL4 and neuronal pro-
moter (elav-GAL4; UAS–Scramb 2; double mutant) rescued 
the content of ECP, RP, mobilization of RP pool of vesicles, 
postsynaptic current amplitude, quantal   content, tetanic facilita-
tion, and posttetanic facilitation to control levels (Fig. S5, available 
at http://www.jcb.org/cgi/content/full/jcb.200506159/DC1). 
In summary, our electrophysiological inquiries indicate that 
several aspects of synaptic function, including spontaneous, 
nerve-evoked release and PTP, are altered in the double mutant.
Despite changes in synaptic structure and physiology, 
overall synaptic function is not compromised in that the viabil-
ity of the animal is not grossly affected in the double mutants. 
Thus, we believe that Scramblases have modulatory function in 
the secretory process of NMJs.
Discussion
Lipids are asymmetrically distributed between the two leafl  ets 
of the plasma membrane. Although the outer leafl  et is enriched 
in choline phospholipids such as phosphatidylcholine and 
sphingomyelin, the inner leafl  et contains anionic phospholipids 
such as PS and phosphatidylethanolamine. Although these 
  lipids have a tendency to equilibrate along their concentration 
gradient, specifi  c proteins that catalyze uni- or bidirectional 
transport of lipids from one leafl   et to another maintain the 
asymmetry. One of the important players in this process is ami-
nophospholipid translocase. Although its molecular identity has 
not been defi  nitively identifi  ed, a P-type ATPase (aminophos-
pholipid translocase) is thought to mediate this function (Wolfs 
et al., 2005). However, certain physiological and pathological 
conditions actively cause collapse of this asymmetry, resulting 
in scrambling of phospholipids. The most notable situation is in 
cells undergoing apoptosis wherein cell surface exposure of PS 
is one of the earliest detectable biochemical events. In fact, the 
annexin V binding assays for apoptotic cells is based on this 
  exposure of PS. PS exposure has also been proposed as one of 
the signals that initiate the phagocytic process in cells targeted 
for phagocytosis. Lipid scrambling is thought to depend on one 
or more membrane proteins with lipid Scramblase activity. 
PLSCR1 was thus purifi  ed and identifi  ed as a putative Scram-
blase based on in vitro assays of transfer of lipids in bilayer. 
Subsequently, three other members of this family were discov-
ered in humans and mice.
Mice lacking PLSCR1 and -3 have been generated. 
  Phenotypic analysis of the mutants indicated that PLSCR1 
mice showed a defective response of hematopoietic precursors 
to granulocyte colony–stimulating and stem cell factors. 
PLSCR3 mice show insulin resistance, glucose intolerance, 
and   dyslipidemia. Both knockout mice show no defects in lipid 
scrambling, suggesting that the presumed activity of this protein 
is not correct or that other members of the PLSCR family maintain 
the Scramblase activity. D. melanogaster has two defi  nitively 
identifi   ed members of this family, and we have generated 
  mutants in both proteins. Analyses of null (or severely hypo-
morphic) Scramblase mutants demonstrate that these proteins 
do not play a critical role in scrambling of phospholipids; 
  instead, they have a modulatory role in the secretory process.
We have demonstrated that D. melanogaster Scramblases 
show an overlapping and ubiquitous expression throughout de-
velopment, and they localize to the plasma membrane in all the 
tissues examined. The ubiquitous distribution suggests their 
participation in general housekeeping function involving plasma 
membrane. We used a Western blot–based genetic screen to 
  obtain null mutants for each of the two Scramblases. We also 
  recombined the two null mutants to generate double mutants 
of Scramblases. The viability and lack of any developmental 
  defects in the single and double mutants and our studies with 
reaper expression in mutant animal backgrounds indicate that 
they do not play a deterministic role in scrambling of phospho-
lipids. This notion is further supported by our data in S2 cells, 
where neither overexpression nor RNAi-mediated knock down 
of these proteins has any effect on the ability of resting or apop-
totic cells to expose PS.
Our studies indicate that loss of both Scramblases results 
in alteration in both the organization and function of the larval 
NMJ. The synaptic phenotype of the double mutant includes an 
increase in the number of vesicles at the synapse (including 
docked vesicles), a fi  vefold increase in RP recruitment at rest, a 
twofold increase in release probability, and an abnormal PTP. 
The fact that the recruitment of vesicles from RP at rest in the 
absence of nerve stimulation is dramatically enhanced in the 
double mutants might explain in part the abnormally elevated 
number of docked vesicles seen in EM analysis. The increased 
cycling of vesicles through the RP, as indicated by the almost 
twofold increase in uptake of FM1-43 (Fig. 7 C), probably as-
sociates with the twofold increase in release probability and 
evoked release seen in the double-mutant synapse (Fig. 8, A and C; 
and Table III). Although increased resting Ca
2+ levels can 
contribute to increased probability of release, we do not believe 
they are contributing to the double-mutant phenotype. For ex-
ample, although RP recruitment at rest in the double mutant is 
enhanced fi  vefold relative to w1118, the probability of release 
is only twofold above normal. Because the cooperative factor of 
Ca
2+ for transmitter release is approximately Ca
4, an increase in 
Ca
2+ at rest in the double mutant would be expected to have a 
much larger effect on release probability than on RP recruitment. 
On the other hand, an enhanced recruitment of SVs from RP 
could contribute to the increased number of SVs available for 
release observed in the double-mutant presynaptic terminals. 
An abnormal handling of Ca
2+ might underlie the enhanced 
probability of release found in double-mutant synapses. Indeed, 
our results indicate a shift to left on the Ca
2+ dependence or 
  release, without a change in Ca
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Ca
2+ handling might be somehow abnormal in double-mutant 
synapses. However, paired-pulse facilitation is only slightly 
  reduced in the double mutant synapse, arguing against a grossly 
abnormal handling of Ca
2+. Also, the rates of ECP exocytosis 
are known to depend signifi  cantly on Ca
2+ (Kuromi and Kidokoro, 
2003). However, contrary to what one would expect if Ca
2+ levels 
were abnormally elevated, we   observed that the rates of ECP 
exocytosis were the same in the control and double-mutant 
  boutons. Thus, our observations would in principle rule out the 
possibility that grossly elevated Ca
2+ levels underlie the abnor-
mal synaptic phenotype observed in double-mutant synapses. 
In D. melanogaster, RP recruitment and transmitter release are 
fostered by elevations in cAMP levels at synaptic boutons, and 
RP recruitment is antagonized by PKA inhibitors (Kuromi and 
Kidokoro, 2000). Importantly, in a dunce mutant, with abnor-
mally elevated cAMP levels, RP size is dramatically reduced, 
probably because of the excess translocation of SVs from RP 
(Kuromi and Kidokoro, 2000). We found that in spite of en-
hanced RP recruitment, RP size remains vigorous in the double 
mutant, as documented in Fig. 7 C. Thus, unlike dunce, en-
hanced RP recruitment in the double mutant is not accompanied 
by a reduced RP size. We cannot rule out the possibility that 
cAMP signaling is altered in double mutant synapses. If so, 
such alteration should allow for a signifi  cant enhancement in 
RP recruitment without a reduction in RP size. In short, our data 
seem to rule out in principle a grossly abnormal handling of 
Ca
2+ or a severely altered operation of the cAMP cascade in 
double-mutant synapses. It is important to note that the effects 
of cAMP on transmitter release are not limited to fostering RP 
recruitment. There is evidence that cAMP-gated channels at the 
presynaptic terminal also play an important role, independent of 
PKA, in enhancing transmitter release in D. melanogaster 
(Cheung et al., 2006). In D. melanogaster, RP dynamics has 
also been associated to the actin cytoskeleton and to the actin 
binding myosin ATPase complex (Kidokoro et al., 2004; 
  Verstreken et al., 2005). Further work should allow us to better 
  understand the role of Scramblases in regulating RP dynamics 
and transmitter release in D. melanogaster. The fact that 
D. melanogaster Scramblases exhibit putative protein binding 
domains means it is possible that they are able to interact with 
other   proteins and signaling pathways to participate in regulat-
ing transmitter secretion and SV traffi  cking at the presynaptic 
  terminal. We provide the fi  rst evidence that Scramblases can 
play an important role in regulating RP recruitment, transmitter 
release, and short-term synaptic memory in D. melanogaster.
We believe that Scramblases have a general role in modu-
lating regulated secretory process. In fact, earlier work done in 
mammalian Scramblases seems to support this notion, although 
this conclusion was not drawn in those studies. In one of the 
earlier studies, Scramblases were found to interact with thrombo-
spondin 1, a secreted protein (Aho and Uitto, 1998).  Interferon α, 
a secreted protein is a known up-regulator of Scramblase 
(Der et al., 1998; Zhou et al., 2000). Human Scramblase has 
been demonstrated to interact with human salivary leukocyte 
protease inhibitor, a secreted protein (Tseng and Tseng, 2000). 
Activation of Mast cells results in degranulation and secretion 
of a host of vasoactive amines, proteases, and proinfl  ammatory 
cytokines. Cultured mast cells RBL-2H3 activated with FcεRI 
resulted in up-regulation and phosphorylation of Scramblase 
protein (Pastorelli et al., 2001). Potentiation of the antiviral 
  action of interferon by Scramblase has also been reported 
(Dong et al., 2004). PLSCR1 interacts with b-secretase (b-site 
amyloid precursor protein–cleaving enzyme), which is involved 
in secretion of the amyloid β-peptide (Kametaka et al., 2003). 
PLSCR1 mutants have no defect in scrambling but have defi  -
cient granulopoiesis, and PLSCR3 mutant mice display adipos-
ity and dyslipidemia. Finally, B lymphocytes from a patient 
with Scott syndrome (whose red blood cells show defective 
scrambling), despite being defi   cient in Scramblase activity, 
have normal levels of PLSCR1, and the nucleotide sequence of 
the corresponding mRNA is identical to controls (Zhou et al., 
1998). All the aforementioned results and our data from analyz-
ing scramb1, scramb2, and the double mutants reveal a role for 
Scramblases in modulating regulated exocytosis and not in the 
scrambling of phospholipids.
Materials and methods
Identiﬁ  cation and cloning of D. melanogaster Scramblases
A BLAST (basic local alignment search tool) search of the D. melanogaster 
genome database using the mammalian Scramb 2 sequence revealed the 
existence of two deﬁ  nitive members of Scramblase family of genes. The 
two Scramblases are Scramblase 67D (Scramb 1) and 63B (Scramb 2). 
D. melanogaster genome annotation project has listed these genes as 
CG1893 and CG32056. CG32056 (Scramb 1) is localized to the 67D 
region on the left arm of third chromosome, and CG1893 gene (Scramb 2) 
is localized to the 63B region on the left arm of third chromosome. 
A BLAST search against the cDNA database revealed the existence of sev-
eral cDNA clones from the D. melanogaster collection maintained at the 
time by the Berkeley Drosophila Genome Project and Research Genetics. 
All clones whose 5′ or 3′ ends showed homology to the mouse Scrambla-
ses were obtained from Research Genetics and sequenced. Full-length 
cDNA clones corresponding to GM13876 for Scramb 1 and GH10494 
for Scramb 2 genes were then used for all subsequent manipulations. The 
Scramblase cDNAs with appropriate cloning restriction sites were ampli-
ﬁ  ed, cloned, and sequenced. For transgenic overexpression in D. melano-
gaster, the appropriate cDNAs were cloned into pUAST vector, and for S2 
cell overexpression they were cloned into pRMHa-3 vector (a gift from 
L. Goldstein, University of California, San Diego, La Jolla, CA).
Fly stocks and husbandry
D. melanogaster stocks were cultured on standard maize meal agar and 
maintained at 25°C unless otherwise mentioned. The Df(3L)AC1 
rnroe-1p
p/
TM3, Sb Df(3L)M21, kni[ri-1]p/In(3L)Rt33[L]f19, w
−; P{w + mC = Actin}-
Gal4 stocks were obtained from Bloomington Stock Center. Cyo, 2× GMR 
Rpr/Sco; MKRS/TM6B ﬂ  ies were obtained from K. White (Massachusetts 
General Hospital, Boston, MA).
Genetic screens and isolation of Scramblase mutants
w1118 males were aged for 3–4 d, starved overnight in empty vials, and 
subjected to chemical mutagenesis by feeding them on a diet of 25 μM EMS 
in 3% sucrose as previously described (Dolph et al., 1993; Acharya et al., 
1998). These ﬂ  ies were then crossed en masse to virgin females with bal-
anced third chromosomes. Single F1 males carrying a mutagenized chro-
mosome over a third chromosome balancer were then crossed to   virgin 
Df(3L)AC1, 
rnroe-1p
p/TM3, Sb, ﬂ  ies in individual vials. The deﬁ  ciency uncovers 
the 67D region. From each of these vials, a single progeny that carried the 
mutagenized chromosome over the deﬁ  ciency was subjected to Western blot 
analysis for the loss of respective Scramblase antigen (Dolph et al., 1993; 
Acharya et al., 1998). Vials with lethal mutations in the interval uncovered 
by the deﬁ  ciency were set aside to be used in transgenic rescue experiments, 
if necessary. Single ﬂ  y heads were homogenized in SDS-PAGE buffer and 
loaded on gels. The separated proteins were transferred to nitrocellulose and 
incubated with afﬁ  nity-puriﬁ  ed rabbit polyclonal antibodies raised against 
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To   outcross all incidental and irrelevant mutations, the null mutant was back-
crossed three times to w1118 ﬂ  ies and selected by Western analysis. A simi-
lar   approach was used to isolate the scramb2 mutant. However, Df(3L)M21, 
kni[ri-1]p/In(3L)Rt33[L]f19, a deﬁ  ciency that uncovers the 63B region, was 
used instead. Again, the null mutant was backcrossed three times to w1118 
controls to outcross all other mutations and selected by Western analysis.
Transgenic ﬂ  ies
The Scramb 2 cDNA was ampliﬁ  ed in frame with open reading frame of 
GFP gene and ligated to generate GFP–Scramb 2 fusion. The gene was 
then cloned into pUAST vector and injected into embryos to generate trans-
genic ﬂ  ies expressing GFP–Scramb 2 fusion. pUAST–Scramb 2–transgenic 
ﬂ  ies were generated. These lines were subsequently crossed to actin-Gal4 
lines to drive its expression ubiquitously. A similar approach was attempted 
for Scramb 1 gene, but no protein was detected in these ﬂ  ies either by 
Western analysis or by immunoﬂ  uorescence. We presumed that the protein 
was misfolded and degraded. An 11.8-Kb Sal1–Kpn1 fragment of geno-
mic DNA spanning the Scramb 1 gene was cloned into pUAST, and trans-
genic lines were obtained. One of these mapped to the second chromosome 
and was used in the transgenic rescue experiments. The transgenic expres-
sion of Scramb 1 protein was conﬁ  rmed by Western analysis in the double-
mutant background.
Antibodies
Rabbit polyclonal and monoclonal antibodies were raised against bacteri-
ally expressed, afﬁ  nity-puriﬁ  ed MBP–Scramb 1 protein in which the Scramb 1 
protein was further cleaved off from MBP by factor Xa cleavage and puri-
ﬁ  ed by electro elution from polyacrylamide gels. Additionally, a COOH-
  terminal peptide antibody was raised against Scramb 1–derived peptide 
CFFEKAGNQETDRPGML   and afﬁ  nity  puriﬁ   ed. Rabbit polyclonal anti-
bodies were raised against Scramb 2 protein expressed using a pET3a ex-
pression system and puriﬁ  ed by SDS-PAGE and electroelution. For Western 
analysis, afﬁ  nity-puriﬁ   ed anti-peptide Scramb 1 antibody was used at 
1:500 dilution and anti–Scramb 2 antibody was used at 1:2,000–1:4,000. 
IPP antibodies were a gift from C. Zuker (University of San Diego, San 
Diego, CA). Anti–Fas II (1:500), anti-synaptotagmin (1:200), anti-cysteine 
string protein (1:25), anti-synataxin (1:200), and anti-DLG (1:200) mono-
clonal antibodies were obtained from Iowa Hybridoma Bank. Afﬁ  nity-
  puriﬁ   ed rabbit anti-synaptotagmin (1:1,000) antibody was a gift from 
M. Ramaswami and S. Sanyal (University of Arizona, Phoenix, AZ). Anti-HRP 
(1:500) and secondary antibodies (1:500) were obtained from Jackson 
ImmunoResearch Laboratories. Anti-CDase (1:3,000) antibodies have 
been described previously (Acharya et al., 2003, 2004; Rohrbough et al., 
2004). The Notch antibody was a gift from M. Fortini (National Cancer 
Institute Frederick, Frederick, MD).
Immunoﬂ  uorescence
Embryos and imaginal discs were collected and prepared for immuno-
ﬂ   uorescent staining as described previously (Patel, 1994). Tissues were 
  incubated overnight with the antibodies (1:100–1:500 for anti–Scramb 1 
monoclonal and anti–Scramb 2 rabbit polyclonal) at 4°C. These were 
  costained with Alexa 568 or 488–conjugated goat anti–rabbit or goat 
anti–mouse IgG for 2 h at room temperature, washed, and mounted on 
Vectashield. For GFP visualization, the wing or eye imaginal discs were 
isolated from wandering third instar larvae, ﬁ  xed in 4% formaldehyde, 
washed, and stained with propidium iodide for nuclear staining. For confo-
cal microscopy, laser-scanning confocal microscopes (models 410 and 
510; Carl Zeiss MicroImaging, Inc.) were used in most experiments, using 
a 63× oil objective, and pictures were obtained at resolutions ranging 
from 512 × 512 to 2048 × 2048. The pictures were pseudocolored in 
Photoshop (Adobe) for use in ﬁ  gures.
Electron microscopic examination
For electron microscopic examinations, wandering third instar larvae 
grown at 25°C were dissected and ﬁ  xed using 2% glutaraldehyde and 4% 
formaldehyde in sodium cacodylate buffer. The tissues were postﬁ  xed in 
1% osmium tetroxide and dehydrated in graded ethanol and propylene 
oxide. Specimens were embedded in epoxy resin (Embed-812) and thin 
sectioned. Transverse sections (90 nm) were stained with uranyl acetate 
and lead citrate and examined.
Genetic crosses
Mutant Scramblase ﬂ  ies (individual and double mutants) were crossed into 
GMR-Rpr background to evaluate the effects of these mutations in reaper-
induced apoptosis. UAS–Scramb 2 GFP ﬂ  ies were crossed to actin-Gal4 to 
drive expression ubiquitously.
Bacterial infections
Bacterial infection experiments were done as described previously (Rodriguez 
et al., 1996; Bernal and Kimbrell, 2000). Escherichia coli, Enterobacter 
cloacae B12, Staphylococcus epidermidis, and Micrococcus reoseus were gifts 
from D. Kimbrell and R. Schoenfeld (University of California, Davis, Davis, CA). 
They were individually grown and pelleted. They were subsequently 
  resuspended in LB collectively and pelleted again. The microorganism mixture 
was then injected into the thorax of individual ﬂ  ies using tungsten needles. 
A group of 10 individual ﬂ  ies were maintained in each vial, and the vials 
were replaced with a fresh vial every day. A total of 100 ﬂ  ies were infected 
for individual samples, and the experiment was repeated three times.
Scrambling index
Scramb 1 and 2 were cloned into pRMHA3 vector, and stable lines were 
established. The proteins were induced with 0.5 mM copper sulfate, and 
cells were harvested after 48 h of induction for Western analysis. A 900-bp 
fragment of Scramb 1 and a 600-bp fragment of Scramb 2 were PCR ampli-
ﬁ  ed with E. coli T7 polymerase site as described previously (Clemens et al., 
2000; Worby et al., 2001) with minor modiﬁ  cations. RNA was synthesized 
using the T7 RNA polymerase kit (QIAGEN). The dsRNA were annealed by 
heating to 75°C for 20 min and slow cooling to room temperature. 1 μg of 
dsRNA was transfected to S2 cells in a 3-cm dish by Ca
2+ phosphate trans-
fection and media changed after 24 h. dsRNA-treated cells were evaluated 
for protein levels by Western analysis at 24, 48, and 72 h after transfection. 
For scrambling (apoptotic) index, stable cells induced for protein production 
for 48 h or cells treated with dsRNA for 48 h were treated with Actino-
mycin D. They were then incubated in annexin V binding buffer (10 mM 
Hepes, pH 7.4, 150 mM NaCl, and 2.5 mM CaCl2) with annexin V–Alexa 
488 propidium iodide. Stained cells were visualized using a confocal 
  microscope (model 510). Approximately 300 cells were counted in three 
different ﬁ  elds for each experimental sample. Cells that were annexin V 
positive and propidium iodide negative were then used to calculate the 
  percentage of cells that exposed PS on the surface (scrambling index).
Electrophysiology
Postsynaptic responses evoked by stimulation of the nerve were recorded 
from segments A2 or A3 of ventral longitudinal muscle 6 or 7 in third instar 
larvae using a two-electrode voltage clamp as reported previously in a 
standard working solution containing 128 mM NaCl, 2 mM KCl, 4 mM 
MgCl2, 0.2 mM CaCl2, 5 mM Hepes, and 36 mM sucrose, pH 7.3. Osmotic 
release of neurotransmitter was achieved by application of a hyperosmotic 
standard solution containing 500 mM sucrose and 50 μM CaCl2 (Acharya 
et al., 1998; Delgado et al., 2000). The currents were recorded at −80 mV 
holding potential, and current amplitudes and integrals were analyzed 
  using pClamp software (Axon Instruments, Inc.). Nerves were cut close to 
the ventral ganglia and sucked into the stimulating pipette. Evoked currents 
were elicited by stimulation of the nerve at the frequencies indicated using 
a programmable stimulator (Master-8; MPI). Data acquisition and analysis 
were done using pClamp software. The quantal content of nerve-evoked 
responses was estimated by dividing the current integral of individual 
nerve-evoked currents by the integral of the current evoked by the release 
of an individual quantum, as described previously (Acharya et al.,
1998; Delgado et al., 2000).
Loading and unloading of FM1-43
Loading of ECP with FM1-43. Dye loading of vesicles cycling through ECP 
was achieved by exposing synaptic boutons for 5 min to high K
+ external 
containing 10 μM FM1-43 (Invitrogen) as described by Kuromi and 
Kidokoro (2000).
Loading of RP with FM1-43. After dye loading of SVs cycling through 
ECP, nerve was stimulated at 10 Hz for 5 min in standard working solution 
containing FM1-43. FM1-43 was then removed by extensive rinsing with 
dye-free standard solution. Then, synaptic boutons were exposed for a sec-
ond time to high K
+ for 3 min to release SVs cycling through ECP, after 
which the external solution was extensively rinsed with standard working 
solution. The remaining FM1-43 ﬂ  uorescence corresponds to SVs cycling 
through the RP (Delgado et al., 2000).
FM1-43 unloading. In all cases, FM1-43 unloading was monitored 
in a standard working solution at rest, in the absence of nerve stimulation 
or by stimulating the nerve at low (0.5 Hz) or high frequency (10 Hz) using 
a programmable stimulator.
Imaging
Synaptic boutons were imaged using an epi-ﬂ  uorescence  microscope 
(BX50WI; Olympus) with a 60× objective. Samples were excited for SCRAMBLASES MODULATE REGULATED EXOCYTOSIS • ACHARYA ET AL. 81
200–300 ms via a controlled shutter system (Uniblitz; Vincent Associates). 
  Images were captured with a 12-bit cooled charge-coupled device camera 
(SensiCam; PCO Imaging). Images were acquired and analyzed using 
Workbench 2.2 software (Axon Imaging). Results are from at least three 
synaptic boutons from a minimum of six different larvae per experimental 
condition. Fluorescence analysis was performed after correcting for bleach-
ing and background.
Online supplemental material
Fig. S1 shows colabeling of Scramblase proteins with plasma membrane 
markers. Fig. S2 shows absence of Scramblase signals in synaptic boutons 
of the double-mutant larval NMJs. Fig. S3 shows staining of segmental 
nerves with Scramblases. Fig. S4 shows that Scramb 2 is present in pre 
and postmembranes of the larval NMJ. Fig. S5 shows rescue of the double-
mutant synaptic phenotype by neuronal expression of Scramb 2. Online 
supplemental material is available at http://www.jcb.org/cgi/content/
full/jcb. 200506159/DC1. 
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